Skip to search formSkip to main contentSkip to account menu

ABP 980

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

trastuzumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
ABP 980: promising trastuzumab biosimilar for HER2-positive breast cancer
ABSTRACT Introduction: Approval of the HER2-targeted antibody trastuzumab dramatically improved outcomes for patients with HER2… 
2016
2016
Abstract P6-13-12: Comparative similarity of ABP 980 and trastuzumab: Results of functional similarity and human pharmacokinetic assessment
Background: ABP 980 is being developed as a biosimilar to trastuzumab, a monoclonal antibody (mAb) that binds human epidermal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)